Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Data center management unit with improved disaster prevention and recovery
Inductance element
Method and system for constructing a customized web analytics application
Packet transmission method, apparatus, and network system
Image processing system, image processing apparatus, control method for image processing apparatus, and storage medium
Locking flange
Carbon blacks having low PAH amounts and methods of making same
  Randomly Featured Patents
Waste bag
Bubble nucleator
System and method for distributed authentication service
Chair type massager
Valve actuation device
Inkjet printer with selectively isolatable pump
Method of producing poly(p-dioxanone), poly (p-dioxanone) monofilaments and method for producing the same
Conveyor row former, array rake and sweep mechanism for conveying objects having triangular cross sections
Separation of nahcolite from oil shale by infrared sorting